| Bioactivity | BDC2.5 mimotope is a potent antigen-mimicking peptide that can activate CD4+ T cell populations that have the same antigen recognition properties as BDC2.5 cells. BDC2.5 mimotope can be used to study the prevention or treatment of type 1 diabetes by targeting specific T cell populations[1]. |
| CAS | 1370451-15-2 |
| Sequence | Ala-His-His-Pro-Ile-Trp-Ala-Arg-Met-Asp-Ala |
| Shortening | AHHPIWARMDA |
| Formula | C58H85N19O14S |
| Molar Mass | 1304.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pujol-Autonell I, et al. Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes[J]. PloS one, 2015, 10(6): e0127057. |
BDC2.5 mimotope
CAS: 1370451-15-2 F: C58H85N19O14S W: 1304.48
BDC2.5 mimotope is a potent antigen-mimicking peptide that can activate CD4+ T cell populations that have the same antig
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.